Sabra Health Care REIT, Inc. (SBRA) Q4 2025 Earnings Call February 13, 2026 2:00 PM EST
Company Participants
Lukas Hartwich – Executive Vice President of Finance
Rick Matros – Chairman, President & CEO
Darrin Smith – Chief Investment Officer, Secretary & Executive VP
Michael Costa – Executive VP, CFO & Treasurer
Conference Call Participants
William John Kilichowski – Wells Fargo Securities, LLC, Research Division
Juan Sanabria – BMO Capital Markets Equity Research
Michael Goldsmith – UBS Investment Bank, Research Division
Austin Wurschmidt – KeyBanc Capital Markets Inc., Research Division
Seth Bergey – Citigroup Inc., Research Division
Michael Stroyeck – Green Street Advisors, LLC, Research Division
Farrell Granath – BofA Securities, Research Division
Alec Feygin – Robert W. Baird & Co. Incorporated, Research Division
Omotayo Okusanya – Deutsche Bank AG, Research Division
Richard Anderson – Cantor Fitzgerald & Co., Research Division
Presentation
Operator
Good day, everyone. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sabra Fourth Quarter 2025 Earnings Call. [Operator Instructions]
I would now like to turn the call over to Lukas Hartwich, Executive Vice President of Finance. Please go ahead, Mr. Hartwich.
Lukas Hartwich
Executive Vice President of Finance
Thank you, and good morning. Before we begin, I want to remind you that we will be making forward-looking statements in our comments and in response to your questions concerning our expectations regarding our future financial position and results of operations, including our earnings guidance for 2026 and our expectations regarding our tenants and operators, and our expectations regarding our acquisition, disposition and investment plans.
These forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including the risks listed in our Form 10-K for the year ended December 31, 2025, as well as in